Articles
Nativis’ platform aims to transform disease treatment on a global scale – “a symphony of cures”
In late 2015, I was approached by the board of Nativis, Inc.to take on the leadership of the company, by then a 13-year-old “startup.”
I had already been on the board of directors for over two years and through first-hand...
Articles
Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)
Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line – LBCT Session at ESC...
Articles
Enhancing process safety and efficiency in the pharmaceutical industry with check Weighing solutions
A look at how pharmaceutical manufacturers can benefit from the use of dynamic checkweighing technology to comply with international standards, increase process safety, productivity and process control.
The need for pharmaceutical manufacturers to rely on technological advancements has never been greater....
Articles
ViscoTec Pharma Dispenser VPHD on the test
With nearly 140 years of success, Henkel holds globally leading market positions both in the consumer and industrial sectors and is well known for brands such as Persil, Schwarzkopf and Loctite. In itsworldwide operating business area“Laundry & Home Care”,Henkel...
Articles
Biofortuna reaches key milestones for ReadyPlex blood group
Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has successfully achieved key milestones in the development of its new blood group genotyping product family ReadyPlex™. This breakthrough has released the...
Research Insight
Boehringer Ingelheim and Harvard scientists establish a research alliance
Boehringer Ingelheim announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of treating fibrotic diseases such as idiopathic pulmonary fibrosis (IPF), chronic kidney disease (CKD) and nonalcoholic...
Research Insight
Mylan Launches First Generic of Nuvigil Tablets
Mylan N.V. announced the U.S. launch of Armodafinil Tablets, 50 mg, 150 mg, 250 mg, a generic version of Cephalon's Nuvigil®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read